GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tevogen Bio Holdings Inc (FRA:G28) » Definitions » Issuance of Debt

Tevogen Bio Holdings (FRA:G28) Issuance of Debt : €-1.23 Mil (TTM As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Tevogen Bio Holdings Issuance of Debt?

Tevogen Bio Holdings's Issuance of Debt for the three months ended in Sep. 2024 was €0.90 Mil.

Tevogen Bio Holdings's Issuance of Debt for the trailing twelve months (TTM) ended in Sep. 2024 was €-1.23 Mil.


Tevogen Bio Holdings Issuance of Debt Historical Data

The historical data trend for Tevogen Bio Holdings's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tevogen Bio Holdings Issuance of Debt Chart

Tevogen Bio Holdings Annual Data
Trend Dec21 Dec22 Dec23
Issuance of Debt
11.06 7.08 1.21

Tevogen Bio Holdings Quarterly Data
Dec21 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.08 -2.13 - - 0.90

Tevogen Bio Holdings Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1.23 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tevogen Bio Holdings Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Tevogen Bio Holdings's Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Tevogen Bio Holdings Business Description

Comparable Companies
Traded in Other Exchanges
Address
15 Independence Boulevard, Warren, NJ, USA, 07059
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes ("CD8+ CTLs" or "CTLs"), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.

Tevogen Bio Holdings Headlines

No Headlines